Screen #
II.B.06.01
MEDC01
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
Our next questions are about Medication for Comorbid Psychiatric Conditions.
Medication for Comorbid Psychiatric Conditions involves the use of medications to treat mental
health problems that often accompany substance use problems. Examples include use of
antidepressants for depression and Posttraumatic Stress Disorder, mood stabilizers for Bipolar
Disorder, and antipsychotics for Psychotic Disorders (such as Schizophrenia).
MEDC01. Are you familiar with Medication for Comorbid Psychiatric Conditions?
1
yes [GO TO QUESTION MEDC01_1a]
0
no [GO TO QUESTION MEDRP01]
Screen #
II.B.06.03
MEDC01_1aa
MEDC01_1ab
MEDC01_1ac
MEDC01_1ad
MEDC01_1ae
MEDC01_1af
MEDC01_1ag
MEDC01_1ah
MEDC01_1ai
MEDC01_1ai_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_1a. How did you and your staff learn about Medication for Comorbid
Psychiatric Conditions?
Choose all that apply
a.
in school
b.
by attending a seminar, conference, or workshop
c.
by reading journal articles
d.
by finding information on the internet
e.
by working with a consultant
f.
by discussing it with colleagues and other treatment programs that have experience
with it
g.
through a clinical supervisor or training program
h.
by participating in research
i.
Other (please specify): ________________
Screen #
II.B.06.02
MEDC01_1b
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_1b. Which of these choices best summarizes your knowledge and experience with
Medication for Comorbid Psychiatric Conditions?
Choose one of the following
a
We are not interested in Medication for Comorbid Psychiatric
Conditions and do not think it would be effective in our program.
[IF SELECTED, GO TO QUESTION MEDC01_2b]
b
We have considered Medication for Comorbid Psychiatric
Conditions but see many pros and cons. [IF SELECTED, GO TO
QUESTION MEDC01_3b]
c
We are planning on using Medication for Comorbid Psychiatric
Conditions in our program, but we haven’t used it yet. [IF
SELECTED, GO TO QUESTION MEDC01_4b]
d
We are using Medication for Comorbid Psychiatric Conditions in
our program, but we haven’t decided whether we are going to make
it a permanent part of our program. [IF SELECTED, GO TO
QUESTION MEDC01_5b]
e
We have made Medication for Comorbid Psychiatric Conditions a
permanent part of our program. [IF SELECTED, GO TO
QUESTION MEDC01_6b]
f
We have used Medication for Comorbid Psychiatric Conditions in
our program in the past, but don’t use it currently. [IF SELECTED,
GO TO QUESTION MEDC01_7b]
Screen #
II.B.06.04
MEDC01_2ba
MEDC01_2bb
MEDC01_2bc
MEDC01_2bd
MEDC01_2be
MEDC01_2bf
MEDC01_2bg
MEDC01_2bh
MEDC01_2bi
MEDC01_2bi_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_2b. What are the reasons you think Medication for Comorbid Psychiatric
Conditions would not be effective in your program?
Choose all that apply
a
it isn’t consistent with our program’s treatment approach and
philosophy
b
it isn’t culturally appropriate
c
it is too structured and we need more flexibility
it hasn’t been studied enough with American Indians or Alaska
d
Natives
e
it doesn’t fit well with the other treatments we use in our program
f
it is too expensive and/or time consuming
g
we don’t have the appropriate staff to do this in our program
some of my staff would refuse to use it
h
i
Other (please specify): ________________
Screen #
II.B.06.05
MEDC01_2c
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_2c. Do you feel any pressure to use Medication for Comorbid Psychiatric
Conditions in your program?
1
yes [GO TO QUESTION MEDC01_2d]
0
no [GO TO QUESTION MEDRP01]
Screen #
II.B.06.06
MEDC01_2da
MEDC01_2db
MEDC01_2dc
MEDC01_2dd
MEDC01_2de
MEDC01_2df
MEDC01_2dg
MEDC01_2dh
MEDC01_2dh
_spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_2d. From what sources do you feel this pressure to use Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
your clients
b
your program’s clinical staff
c
your supervisor
tribal/program leadership
d
e
state accreditation organization/Single State Authorities
f
Medicaid, Medicare, or other insurance requirements
g
grant requirements
h
Other (please specify): ________________
[GO TO QUESTION MEDRP01]
Screen #
II.B.06.08
MEDC01_3ba
MEDC01_3bb
MEDC01_3bc
MEDC01_3bd
MEDC01_3be
MEDC01_3bf
MEDC01_3bg
MEDC01_3bh
MEDC01_3bi
MEDC01_3bj
MEDC01_3bj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_3b. What do you see as the “pros” of Medication for Comorbid Psychiatric
Conditions?
Choose all that apply
a.
it is consistent with our program’s treatment approach and philosophy
b.
it is culturally appropriate
c.
the existing research base proves it is effective
d.
it is innovative and promotes good practice
e.
it fits with the expertise and training of our staff
f.
it ensures consistent and standardized treatment within our program
g.
it is a billable service
h.
it can be marketed for political purposes and/or funding requests
i.
its raises the reputation of our program
j.
Other (please specify): ________________
Screen #
II.B.06.09
MEDC01_3ca
MEDC01_3cb
MEDC01_3cc
MEDC01_3cd
MEDC01_3ce
MEDC01_3cf
MEDC01_3cg
MEDC01_3ch
MEDC01_3ci
MEDC01_3ci_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_3c. What do you see as the “cons” of Medication for Comorbid Psychiatric
Conditions?
Choose all that apply
a
it isn’t consistent with our program’s treatment approach and
philosophy
b
it isn’t culturally appropriate
c
it is too structured and we need more flexibility
it hasn’t been studied enough with American Indians or Alaska
d
Natives
e
it doesn’t fit well with the other treatments we use in our program
f
it is too expensive and/or time consuming
g
we don’t have the appropriate staff to do this in our program
some of my staff would refuse to use it
h
i
Other (please specify): ________________
Screen #
II.B.06.10
MEDC01_3d
II.B.06.11
MEDC01_3ea
MEDC01_3eb
MEDC01_3ec
MEDC01_3ed
MEDC01_3ee
MEDC01_3ef
MEDC01_3eg
MEDC01_3eh
MEDC01_3eh
_spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Condition)
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_3d. Do you feel any pressure to use Medication for Comorbid Psychiatric
Conditions in your program?
1
yes [GO TO QUESTION MEDC01_3e]
0
no [GO TO QUESTION MEDRP01]
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_3e. From what sources do you feel this pressure to use Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
your clients
b
your program’s clinical staff
c
your supervisor
d
tribal/program leadership
e
state accreditation agency/Single State Authority
f
Medicaid, Medicare, or other insurance requirements
g
grant requirements
h
Other (please specify): ________________
[GO TO QUESTION MEDRP01]
Screen #
II.B.06.13
MEDC01_4ba
MEDC01_4bb
MEDC01_4bc
MEDC01_4bd
MEDC01_4be
MEDC01_4bf
MEDC01_4bg
MEDC01_4bh
MEDC01_4bi
MEDC01_4bj
MEDC01_4bj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_4b. What do you and your staff like about Medication for Comorbid Psychiatric
Conditions?
Choose all that apply
a.
it is consistent with our program’s treatment approach and
philosophy
b.
it is culturally appropriate
c.
the existing research base proves it is effective
d.
it is innovative and promotes good practice
e.
it fits with the expertise and training of our staff
f.
it ensures consistent and standardized treatment within our program
g.
it is a billable service
h.
it can be marketed for political purposes and/or funding requests
i.
its use raises the reputation of our program
j.
Other (please specify): ________________
Domain/Co
Screen #
nstructs
II.B.06.14
MEDC
• Specific
MEDC –
Dissemina
tion and
MEDC01_4ca
Follow-up
MEDC01_4cb
Questions
MEDC01_4cc
(Medicatio
MEDC01_4cd
n for
MEDC01_4ce
Comorbid
MEDC01_4ce_
Psychiatri
spec
c
Conditions
MEDC01_4c_
)
1
II.B.06.15
MEDC01_4e
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_4c. What type of provider will you use to include Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
psychiatrist
b
other physician (e.g., family practitioner, internist)
c
advanced practice nurse (APN) or nurse practitioner (NP)
d
physician assistant (PA)
e
Other (please specify): ________________
MEDC01_4c_1. Will this provider be a member of your program’s staff, or will this
provider be an outside consultant?
Choose one of the following
1
a member of our program’s staff
0
an outside consultant
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC
• Specific
MEDC –
MEDC01_4e. How do you plan on using Medication for Comorbid Psychiatric
Dissemina
Conditions in your program?
tion and
Choose one of the following
Follow-up
a
it will be a core component of our program and every client will
Questions
receive it
(Medicatio
b
it will be used with clients that will be most likely to benefit from it
n for
c
we haven’t decided how we are going to use it in our program
Comorbid
Psychiatri
c
Condition)
Screen #
II.B.06.16
MEDC01_4fa
MEDC01_4fb
MEDC01_4fc
MEDC01_4fd
MEDC01_4fe
MEDC01_4ff
MEDC01_4fg
MEDC01_4fh
MEDC01_4fi
MEDC01_4fj
MEDC01_4fj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_4f. Do you and your staff have any of the following concerns about using
Medication for Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
we are concerned that it isn’t fully consistent with our program’s
treatment approach and philosophy
b
we are concerned about its cultural appropriateness
c
we worry that it is too structured and we need more flexibility
we are concerned that it hasn’t been studied enough with American
d
Indians or Alaska Natives
e
we aren’t sure if it will fit well with the other treatments we use in
our program
f
we are concerned it is too expensive and/or time consuming to use
we are concerned that we may not have the appropriate staff to
g
implement it effectively
h
we are concerned that some of our staff would refuse to use it
i
we have no concerns about it
Other (please specify): ________________
j
Screen #
II.B.06.17
MEDC01_4g
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_4g. Do you feel any pressure to use Medication for Comorbid Psychiatric
Conditions in your program?
1
yes [GO TO QUESTION MEDC01_4h]
0
no [GO TO QUESTION MEDRP01]
Screen #
II.B.06.18
MEDC01_4ha
MEDC01_4hb
MEDC01_4hc
MEDC01_4hd
MEDC01_4he
MEDC01_4hf
MEDC01_4hg
MEDC01_4hh
MEDC01_4hh
_spec
MEDC01_4i
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_4h. From what sources do you feel this pressure to use Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
your clients
b
your program’s clinical staff
c
your supervisor
d
tribal/program leadership
state accreditation organization/Single State Authority
e
f
Medicaid, Medicare, or other insurance requirements
g
grant requirements
h
Other (please specify): ________________
MEDC01_4i. Are these pressures part of the reason you are considering using Medication
for Comorbid Psychiatric Conditions in your program?
1
yes
0
no
[GO TO QUESTION MEDRP01]
Screen #
II.B.06.20
MEDC01_5b
II.B.06.21
MEDC01_5c
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5b. How long have you used Medication for Comorbid Psychiatric Conditions in
your program?
Choose one of the following
a
less than 6 months
b
6 months to 1 year
c
2 to 5 years
d
more than 5 years
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5c. Did you feel any pressure to use Medication for Comorbid Psychiatric
Conditions in your program?
1
yes [GO TO QUESTION MEDC01_5d]
0
no [GO TO QUESTION MEDC01_5f]
Screen #
II.B.06.22
MEDC01_5da
MEDC01_5db
MEDC01_5dc
MEDC01_5dd
MEDC01_5de
MEDC01_5df
MEDC01_5dg
MEDC01_5dh
MEDC01_5dh
_spec
MEDC01_5e
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5d. From what sources did you feel this pressure to use Medication for
Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
your clients
b
your program’s clinical staff
c
your supervisor
d
tribal/program leadership
state accreditation organization/Single State Authority
e
f
Medicaid, Medicare, or other insurance requirements
g
grant requirements
h
Other (please specify): ________________
MEDC01_5e. Are these pressures part of the reason you are using Medication for
Comorbid Psychiatric Conditions in your program?
1
yes
0
no
Screen #
II.B.06.23
MEDC01_5fa
MEDC01_5fb
MEDC01_5fc
MEDC01_5fd
MEDC01_5fe
MEDC01_5ff
MEDC01_5fg
MEDC01_5fh
MEDC01_5fi
MEDC01_5fj
MEDC01_5fk
MEDC01_5fl
MEDC01_5fl_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5f. What were the other reasons that you and your staff decided to use Medication
for Comorbid Psychiatric Conditions in your program?
Choose all that apply
a.
it is consistent with our program’s treatment approach and
philosophies
b.
it is culturally appropriate
c.
the existing research base proves it is effective
d.
it is innovative and promotes good practice
e.
it fits with the expertise and training of our staff
f.
it ensures consistent and standardized treatment within our program
g.
it is a billable service
h.
it can be marketed for political purposes and/or funding requests
i.
its use raises the reputation of our program
j.
No other reasons
k.
don’t know – we made this decision before I joined the program
l.
Other (please specify): ________________
Screen #
II.B.06.24
MEDC01_5ga
MEDC01_5gb
MEDC01_5gc
MEDC01_5gd
MEDC01_5ge
MEDC01_5ge
_spec
MEDC01_5g_
1
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5g. What type of provider do you use to include Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
psychiatrist
b
other physician (e.g., family practitioner, internist)
c
advanced practice nurse (APN) or nurse practitioner (NP)
d
physician assistant (PA)
e
Other (please specify): ________________
MEDC01_5g_1. Is this provider a member of your program’s staff, or is this provider an
outside consultant?
Choose one of the following
1
a member of our program’s staff
0
an outside consultant
Screen #
II.B.06.25
MEDC01_5i
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5i. How do you and your staff use Medication for Comorbid Psychiatric
Conditions in your program?
Choose one of the following
a
it is a core component of our program and every client receives it
b
we use it with clients that will most likely benefit from it
Screen #
II.B.06.27
MEDC01_5ja
MEDC01_5jb
MEDC01_5jc
MEDC01_5jd
MEDC01_5je
MEDC01_5jf
MEDC01_5jf_
spec
MEDC01_5k
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5j. How do you evaluate the outcomes of Medication for Comorbid Psychiatric
Conditions in your program?
Choose all that apply
a
staff meetings and discussions
b
client satisfaction questionnaires
c
client outcomes surveys and interviews
d
treatment record audits/reviews
we haven’t evaluated it
e
f
Other (please specify): ________________
MEDC01_5k. How effective has Medication for Comorbid Psychiatric Conditions been in
your program?
Choose one of the following
a
not effective at all
b
somewhat effective
c
very effective
Screen #
II.B.06.28
MEDC01_5l_1
MEDC01_5l_2
MEDC01_5l_3
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5l_1. How satisfied are you with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
b
somewhat satisfied
c
very satisfied
MEDC01_5l_2. How satisfied are your staff with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
b
somewhat satisfied
very satisfied
c
MEDC01_5l_3. How satisfied are your clients with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
somewhat satisfied
b
c
very satisfied
Screen #
II.B.06.30
MEDC01_5oa
MEDC01_5ob
MEDC01_5oc
MEDC01_5od
MEDC01_5oe
MEDC01_5of
MEDC01_5og
MEDC01_5og
_spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5o. How do you monitor your staff’s use of Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
staff meetings
b
individual discussions with clinical supervisor
c
treatment record audits/reviews
d
reviews of audio or video recordings of sessions
direct observation of sessions by clinical supervisor
e
f
we haven’t monitored our staff’s use of Medication for Comorbid
Psychiatric Conditions
g
Other (please specify): ________________
Screen #
II.B.06.31
MEDC01_5pa
MEDC01_5pb
MEDC01_5pc
MEDC01_5pd
MEDC01_5pe
MEDC01_5pf
MEDC01_5pg
MEDC01_5ph
MEDC01_5pi
MEDC01_5pj
MEDC01_5pj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5p. Do you and your staff have any of the following concerns about using
Medication for Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
it isn’t fully consistent with our program’s treatment approach and
philosophy
b
we are concerned about its cultural appropriateness
c
it is too structured and we need more flexibility in treating our
clients
we are concerned that it hasn’t been studied enough with American
d
Indians or Alaska Natives
e
it doesn’t fit well with the other treatments we use in our program
f
it is expensive and/or time consuming
we are concerned that we really don’t have the appropriate staff to
g
use it effectively in our program
h
some of our staff refuse to use it
i
we have no concerns about it
Other (please specify): ________________
j
Screen #
II.B.06.32
MEDC01_5qa
MEDC01_5qb
MEDC01_5qc
MEDC01_5qd
MEDC01_5qe
MEDC01_5qf
MEDC01_5qg
MEDC01_5qh
MEDC01_5qi
MEDC01_5qi_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_5q. Why are you unsure whether you will make Medication for Comorbid
Psychiatric Conditions a permanent part of your program?
Choose all that apply
a
it isn’t consistent with our program’s treatment approach and
philosophy
b
it isn’t culturally appropriate
c
it is too structured and we need more flexibility in treating our
clients
it hasn’t been studied enough with American Indians or Alaska
d
Natives
e
it doesn’t fit well with the other treatments we use in our program
f
it is too expensive and/or time consuming
we don’t have the appropriate staff to do this in our program
g
h
some of my staff would refuse to use it
i
Other (please specify): ________________
[GO TO QUESTION MEDRP01]
Screen #
II.B.06.34
MEDC01_6b
II.B.06.35
MEDC01_6c
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6b. How long have you used Medication for Comorbid Psychiatric Conditions in
your program?
Choose one of the following
a
less than 6 months
b
6 months to 1 year
c
2 to 5 years
d
more than 5 years
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6c. Did you feel any pressure to use Medication for Comorbid Psychiatric
Conditions in your program?
1
yes [GO TO QUESTION MEDC01_6d]
0
no [GO TO QUESTION MEDC01_6f]
Screen #
II.B.06.36
MEDC01_6da
MEDC01_6db
MEDC01_6dc
MEDC01_6dd
MEDC01_6de
MEDC01_6df
MEDC01_6dg
MEDC01_6dh
MEDC01_6dh
_spec
MEDC01_6e
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6d. From what sources did you feel this pressure to use Medication for
Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
your clients
b
your program’s clinical staff
c
your supervisor
d
tribal/program leadership
state accreditation organization/Single State Authority
e
f
Medicaid, Medicare, or other insurance requirements
g
grant requirements
h
Other (please specify): ________________
MEDC01_6e. Are these pressures part or all of the reason you are using Medication for
Comorbid Psychiatric Conditions in your program?
1
yes
0
no
Screen #
II.B.06.37
MEDC01_6fa
MEDC01_6fb
MEDC01_6fc
MEDC01_6fd
MEDC01_6fe
MEDC01_6ff
MEDC01_6fg
MEDC01_6fh
MEDC01_6fi
MEDC01_6fj
MEDC01_6fk
MEDC01_6fl
MEDC01_6fl_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6f. What were the other reasons that you and your staff decided to use Medication
for Comorbid Psychiatric Conditions in your program?
Choose all that apply
a.
it is consistent with our program’s treatment approach and
philosophies
b.
it is culturally appropriate
c.
the existing research base proves it is effective
d.
it is innovative and promotes good practice
e.
it fits with the expertise and training of our staff
f.
it ensures consistent and standardized treatment within our program
g.
it is a billable service
h.
it can be marketed for political purposes and/or funding requests
i.
its use raises the reputation of our program
j.
No other reasons
k.
don’t know – we made this decision before I joined the program
l.
Other (please specify): ________________
Screen #
II.B.06.38
MEDC01_6ga
MEDC01_6gb
MEDC01_6gc
MEDC01_6gd
MEDC01_6ge
MEDC01_6ge
_spec
MEDC01_6g_
1
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6g. What type of provider do you use to include Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
psychiatrist
b
other physician (e.g., family practitioner, internist)
c
advanced practice nurse (APN) or nurse practitioner (NP)
d
physician assistant (PA)
e
Other (please specify): ________________
MEDC01_6g_1. Is this provider a member of your program’s staff, or is this provider an
outside consultant?
Choose one of the following
1
a member of our program’s staff
0
an outside consultant
Screen #
II.B.06.39
MEDC01_6i
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6i. How do you and your staff use Medication for Comorbid Psychiatric
Conditions in your program?
Choose one of the following
a
it is a core component of our program and every client receives it
b
we use it with clients that are most likely to benefit from it
Domain/Co
Screen #
nstructs
II.B.06.41
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
MEDC01_6ka
Questions
MEDC01_6kb
(Medicatio
MEDC01_6kc
n for
MEDC01_6kd
Comorbid
MEDC01_6ke
Psychiatri
MEDC01_6kf
c
MEDC01_6kf_
Conditions
spec
)
MEDC01_6l
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6k. How do you evaluate the outcomes of Medication for Comorbid Psychiatric
Conditions in your program?
Choose all that apply
a
staff meetings and discussions
b
client satisfaction questionnaires
c
client outcomes surveys and interviews
d
treatment record audits/reviews
we haven’t evaluated it
e
f
Other (please specify): ________________
MEDC01_6l. How effective has Medication for Comorbid Psychiatric Conditions been in
your program?
Choose one of the following
a
not effective at all
b
somewhat effective
c
very effective
Screen #
II.B.06.43
MEDC01_6l_1
MEDC01_6l_2
MEDC01_6l_3
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6l_1. How satisfied are you with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
b
somewhat satisfied
c
very satisfied
MEDC01_6l_2. How satisfied are your staff with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
b
somewhat satisfied
very satisfied
c
MEDC01_6l_3. How satisfied are your clients with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
somewhat satisfied
b
c
very satisfied
Screen #
II.B.06.44
MEDC01_6oa
MEDC01_6ob
MEDC01_6oc
MEDC01_6od
MEDC01_6oe
MEDC01_6of
MEDC01_6og
MEDC01_6og
_spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6o. How do you monitor how well your staff uses Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
staff meetings
b
individual discussions with clinical supervisor
c
treatment record audits/reviews
d
reviews of audio or video recordings of sessions
direct observation of sessions by clinical supervisor
e
f
we haven’t monitored our staff’s use of Medication for Comorbid
Psychiatric Conditions
g
Other (please specify): ________________
Screen #
II.B.06.45
MEDC01_6pa
MEDC01_6pb
MEDC01_6pc
MEDC01_6pd
MEDC01_6pe
MEDC01_6pf
MEDC01_6pg
MEDC01_6ph
MEDC01_6pi
MEDC01_6pj
MEDC01_6pj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6p. Do you and your staff have any of the following concerns about using
Medication for Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
it isn’t fully consistent with our program’s treatment approach and
philosophy
b
we are concerned about its cultural appropriateness
c
it is too structured and we need more flexibility in treating our
clients
we are concerned that it hasn’t been studied enough with American
d
Indians or Alaska Natives
e
it doesn’t fit well with the other treatments we use in our program
f
it is expensive and/or time consuming to use
we are concerned that we really don’t have the appropriate staff to
g
use it effectively in our program
h
some of our staff refuse to use it
i
we have no concerns about it
Other (please specify): ________________
j
Screen #
II.B.06.46
MEDC01_6qa
MEDC01_6qb
MEDC01_6qc
MEDC01_6qd
MEDC01_6qe
MEDC01_6qf
MEDC01_6qg
MEDC01_6qh
MEDC01_6qi
MEDC01_6qj
MEDC01_6qk
MEDC01_6ql
MEDC01_6ql_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_6q. Why did you decide to make Medication for Comorbid Psychiatric
Conditions a permanent part of your program?
Choose all that apply
a
it is effective
b
our clients like it
c
it is billable
d
it is consistent with our program’s treatment approach and
philosophy
it is culturally appropriate
e
f
it fits with the expertise and training of our staff
g
it fits well with the other treatments we use in our program
h
it is innovative and promotes good practice
it ensures consistent and standardized treatment within our program
i
j
it can be marketed for political purposes and/or funding requests
k
its use raises the reputation of our program
l
Other (please specify): ________________
Screen #
II.B.06.48
MEDC01_7b
MEDC01_7c
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7b. How long did you use Medication for Comorbid Psychiatric Conditions in
your program?
Choose one of the following
a
less than 6 months
b
6 months to 1 year
c
2 to 5 years
d
more than 5 years
MEDC01_7c. How long ago did you stop using Medication for Comorbid Psychiatric
Conditions in your program?
Choose one of the following
a
less than 6 months ago
6 months to 1 year ago
b
c
2 to 5 years ago
d
more than 5 years ago
Screen #
II.B.06.49
MEDC01_7d
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7d. Did you feel any pressure to use Medication for Comorbid Psychiatric
Conditions in your program?
1
yes [GO TO QUESTION MEDC01_7e]
0
no [GO TO QUESTION MEDC01_7g]
Screen #
II.B.06.50
MEDC01_7ea
MEDC01_7eb
MEDC01_7ec
MEDC01_7ed
MEDC01_7ee
MEDC01_7ef
MEDC01_7eg
MEDC01_7eh
MEDC01_7eh
_spec
MEDC01_7f
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7e. From what sources did you feel this pressure to use Medication for
Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
your clients
b
your program’s clinical staff
c
your supervisor
d
tribal/program leadership
state accreditation organization/Single State Authority
e
f
Medicaid, Medicare, or other insurance requirements
g
grant requirements
h
Other (please specify): ________________
MEDC01_7f. Are these pressures part or all of the reason you used Medication for
Comorbid Psychiatric Conditions in your program?
1
yes
0
no
Screen #
II.B.06.51
MEDC01_7ga
MEDC01_7gb
MEDC01_7gc
MEDC01_7gd
MEDC01_7ge
MEDC01_7gf
MEDC01_7gg
MEDC01_7gh
MEDC01_7gi
MEDC01_7gj
MEDC01_7gj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7g. What were the other reasons that you and your staff decided to use
Medication for Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
it is consistent with our program’s treatment approach and
philosophy
b
the existing research base proves it is effective
c
it is innovative and promotes good practice
it ensures consistent and standardized treatment within our program
d
e
it is a billable service
f
it can be marketed for political purposes and/or funding requests
g
its use raises the reputation of our program
h
No other reasons
don’t know – we made this decision before I joined the program
i
j
Other (please specify): ________________
Screen #
II.B.06.52
MEDC01_7ha
MEDC01_7hb
MEDC01_7hc
MEDC01_7hd
MEDC01_7he
MEDC01_7he
_spec
MEDC01_7h_
1
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7h. What type of provider did you use to include Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
psychiatrist
b
other physician (e.g., family practitioner, internist)
c
advanced practice nurse (APN) or nurse practitioner (NP)
d
physician assistant (PA)
e
Other (please specify): ________________
MEDC01_7h_1. Was this provider a member of your program’s staff, or was this provider
an outside consultant?
Choose one of the following
1
a member of our program’s staff
0
an outside consultant
Screen #
II.B.06.53
MEDC01_7j
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7j. How did you and your staff use Medication for Comorbid Psychiatric
Conditions in your program?
Choose one of the following
a
it is a core component of our program and every client receives it
b
we use it with clients that are most likely to benefit from it
Screen #
II.B.06.55
MEDC01_7la
MEDC01_7lb
MEDC01_7lc
MEDC01_7ld
MEDC01_7le
MEDC01_7lf
MEDC01_7lf_
spec
MEDC01_7m
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7l. How did you evaluate the outcomes of Medication for Comorbid Psychiatric
Conditions in your program?
Choose all that apply
a
staff meetings and discussions
b
client satisfaction questionnaires
c
client outcomes surveys and interviews
d
treatment record audits/reviews
we didn’t evaluate it
e
f
Other (please specify): ________________
MEDC01_7m. How effective was Medication for Comorbid Psychiatric Conditions in
your program?
Choose one of the following
a
not effective at all
b
somewhat effective
c
very effective
Screen #
II.B.06.56
MEDC01_7l_1
MEDC01_7l_2
MEDC01_7l_3
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7l_1. How satisfied were you with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
b
somewhat satisfied
c
very satisfied
MEDC01_7l_2. How satisfied were your staff with Medication for Comorbid Psychiatric
Conditions?
Choose one of the following
a
not satisfied
b
somewhat satisfied
very satisfied
c
MEDC01_7l_3. How satisfied were your clients with Medication for Comorbid
Psychiatric Conditions?
Choose one of the following
a
not satisfied
somewhat satisfied
b
c
very satisfied
Screen #
II.B.06.58
MEDC01_7pa
MEDC01_7pb
MEDC01_7pc
MEDC01_7pd
MEDC01_7pe
MEDC01_7pf
MEDC01_7pg
MEDC01_7pg
_spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7p. How did you monitor your staff’s use of Medication for Comorbid
Psychiatric Conditions in your program?
Choose all that apply
a
staff meetings and discussions
b
clinical supervision
c
treatment record audits/reviews
d
reviews of audio or video recordings of sessions
direct observation of sessions by clinical supervisor
e
f
we haven’t monitored our staff’s use of Medication for Comorbid
Psychiatric Conditions
g
Other (please specify): ________________
Screen #
II.B.06.59
MEDC01_7qa
MEDC01_7qb
MEDC01_7qc
MEDC01_7qd
MEDC01_7qe
MEDC01_7qf
MEDC01_7qg
MEDC01_7qh
MEDC01_7qi
MEDC01_7qj
MEDC01_7qj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7q. Did you and your staff have any of the following concerns about using
Medication for Comorbid Psychiatric Conditions in your program?
Choose all that apply
a
it wasn’t fully consistent with our program’s treatment approach and
philosophy
b
we were concerned about its cultural appropriateness
c
it was too structured and we need more flexibility in treating our
clients
we were concerned that it hasn’t been studied enough with
d
American Indians or Alaska Natives
e
it didn’t fit well with the other treatments we use in our program
f
it was too expensive and/or time consuming to use
we were concerned that we really don’t have the appropriate staff to
g
use it effectively in our program
h
some of our staff refused to use it
i
we had no concerns about it
Other (please specify): ________________
j
Screen #
II.B.06.60
MEDC01_7ra
MEDC01_7rb
MEDC01_7rc
MEDC01_7rd
MEDC01_7re
MEDC01_7rf
MEDC01_7rg
MEDC01_7rh
MEDC01_7ri
MEDC01_7rj
MEDC01_7rj_
spec
Domain/Co
nstructs
MEDC
• Specific
MEDC –
Dissemina
tion and
Follow-up
Questions
(Medicatio
n for
Comorbid
Psychiatri
c
Conditions
)
Questions
INTRODUCTION > BACKGROUND > WORKFORCE > ASSESSMENT/TREATMENT >
EVIDENCE-BASED TREATMENTS > QUALITY & LEARNING
MEDC01_7r. Why did you stop using Medication for Comorbid Psychiatric Conditions in
your program?
Choose all that apply
a
it wasn’t effective for our clients
b
our clients didn’t like it
c
it was too expensive and/or too time consuming to use
d
it wasn’t fully consistent with our program’s treatment approach and
philosophy
we were concerned about its cultural appropriateness
e
f
it was too structured and we need more flexibility in treating our
clients
g
it didn’t fit well with the other treatments we use in our program
we didn’t have the appropriate staff to continue to use it in our
h
program
i
some of our staff refused to use it
j
Other (please specify): ________________
[GO TO QUESTION MEDRP01]